SCHEMBL16982124

SCHEMBL16982124

COc1ccc(/C=C/C2CCC=CC2c2ccc(OC)c(OC)c2)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP1A1 P04798 6/20 0.41
CYP1B1 Q16678 5/20 0.41
TUBB4A P04350 4/20 0.41
TUBB P07437 4/20 0.41
TUBA3C P0DPH7 4/20 0.41
TUBA1B P68363 4/20 0.41
TUBA4A P68366 4/20 0.41
TUBB4B P68371 4/20 0.41
TUBB3 Q13509 4/20 0.41
TUBB2A Q13885 4/20 0.41
TUBB8 Q3ZCM7 4/20 0.41
TUBA3E Q6PEY2 4/20 0.41
TUBA1A Q71U36 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21780878 1.00 ALDH1A1 (0.42) ALDH1A1HPGDSMN1; SMN2KDM4EALOX15
SCHEMBL31238162 1.00 ALDH1A1 (0.42) ALDH1A1HPGDSMN1; SMN2KDM4EALOX15
SCHEMBL21780957 0.93 TUBB4A (0.52) ALDH1A1HPGDSMN1; SMN2KDM4EALOX15
SCHEMBL16978040 0.89 KDM4E (0.36) ALDH1A1HPGDSMN1; SMN2KDM4EALOX15
SCHEMBL28238743 0.86 CYP1A1 (0.43) CYP1A1CYP1B1TUBB4ATUBBTUBA3C
SCHEMBL28238742 0.86 CYP1A1 (0.43) CYP1A1CYP1B1TUBB4ATUBBTUBA3C
SCHEMBL28238744 0.86 CYP1A1 (0.43) CYP1A1CYP1B1TUBB4ATUBBTUBA3C
SCHEMBL21767999 0.82 PDE4B (0.42) ALDH1A1KDM4EALOX15MAPK1CYP1A2
SCHEMBL21767998 0.82 PDE4B (0.42) ALDH1A1KDM4EALOX15MAPK1CYP1A2
SCHEMBL21780944 0.78 CYP1A1 (0.44) ALDH1A1HPGDSMN1; SMN2KDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3616692-A1 PHARMACEUTICAL COMPOSITION, CONTAINING NM23 ACTIVATOR, FOR INHIBITING CANCER METASTASIS Ewha University-Industry Collaboration Foundation (KR) 2020-03-04 EP disclosed
US-9511035-B2 Java ginger extract and manufacturing method HOSODA SHC INC. (JP) 2016-12-06 US disclosed
US-20150216818-A1 JAVA GINGER EXTRACT AND MANUFACTURING METHOD HOSODA SHC INC. (JP) 2015-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150216818-A1 JAVA GINGER EXTRACT AND MANUFACTURING METHOD BDNF, NGF, NEFM ALDH1A1 2174/4885HPGD 194/4885SMN1; SMN2 1491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.